Skip to main content
Clinical Trials/NCT03666013
NCT03666013
Completed
Not Applicable

Mitochondrial Health and Muscle Function in Elderly

Maastricht University1 site in 1 country59 target enrollmentJune 27, 2017
ConditionsMuscle Weakness

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle Weakness
Sponsor
Maastricht University
Enrollment
59
Locations
1
Primary Endpoint
Rate of ex vivo mitochondrial State 3 respiration
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to characterize the relation between skeletal muscle mitochondrial metabolism and muscle health in elderly, physically compromised humans. To study this relation, a cross-sectional study will be performed in well-defined, distinct subject groups. Thus, to obtain insight in the relation between mitochondrial health and muscle function, not only subjects that differ in mitochondrial function (based on physical activity) will be compared but also subjects with high- versus low muscle function will be selected.

Detailed Description

Aging is associated with a decline of mitochondrial and skeletal muscle volume, -quality and -function. If a causal link exists between the loss of mitochondrial function and muscle health is unknown, however, both appear with advancing age and are associated with the loss of functional capacity, which increases comorbidities and annual healthcare costs. The aim is to test the hypothesis that a compromised muscle function in sedentary elderly is related to an impaired mitochondrial health. A detailed characterization of mitochondrial metabolism and muscle function is performed in well-defined, (physically compromised) elderly humans, in a cross-sectional design. To obtain insight in the relation between mitochondrial health and muscle function, not only elderly subjects that differ in mitochondrial function (based on physical activity) will be compared but also elderly subjects with high versus low muscle physical function will be selected. Healthy, young (20-30 years,) individuals with normal physical activity levels will be included as absolute controls.

Registry
clinicaltrials.gov
Start Date
June 27, 2017
End Date
April 9, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Males and females
  • Subject should be in sufficient health to participate in the experimentations, to be judged by the responsible MD based on the subject's medical history
  • Caucasian origin (see study groups)

Exclusion Criteria

  • Any contraindications for MRI scan:
  • Aneurysm clips Implanted neural stimulator Implanted cardiac pacemaker of defibrillator Cochlear implant Iron- containing corpora aliena in the eye or brain Artificial (heart) valves which is contraindicated for MRS Claustrophobia
  • Diagnosed with diabetes mellitus
  • Poor health as judged by the responsible medical doctor
  • Heart problems: In case of an abnormal ECG in rest, this will be discussed with both the participant and the responsible medical doctor

Outcomes

Primary Outcomes

Rate of ex vivo mitochondrial State 3 respiration

Time Frame: Day 4

Ex vivo mitochondrial capacity, ADP-stimulated respiration expressed by O2flux in pmol/mg wet weight/second

Secondary Outcomes

  • Insuline sensitivity(Day 1)
  • Body composition(Day 3)
  • Muscle strength in upper-leg(Day 3)
  • Muscle metabolism in vivo (H-MRS acetylcarnitine)(Day 5)
  • Muscle volume upper-leg(Day 5)
  • Physical functionality, 6MWT(Day 2)
  • VO2max(Day 2)
  • Dynamic gait stability(Day 3)
  • Muscle oxidative capacity in vivo (PCr-MRS recovery)(Day 5)
  • Energy expenditure in rest and during sub-maximal exercise(Day 4)

Study Sites (1)

Loading locations...

Similar Trials